Similar increase in circulating renin after equihypotensive doses of nitroprusside, dihydralazine or isradipine in conscious rabbits.
Calcium entry blockers but not nitroprusside sodium (NPS) or dihydralazine are known to enhance renin release in vitro. Isradipine (PN200-110), NPS or dihydralazine were infused at 15 min intervals into groups of 6 conscious, chronically instrumented rabbits each, at 3 doses carefully matched to elicit comparable falls in blood pressure. Plasma renin activity increased similarly with all treatments. In intact animals, the magnitude of the pressure decrease appears to be more important for renin release than the mechanism of vasodilation and a typical calcium entry blocker was indistinguishable from other vasodilators.
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004078:Dihydralazine / Q000494:pharmacology*; D005260:Female; D005292:Ferricyanides / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects; D006830:Hydralazine / Q000031:analogs & derivatives*; D017275:Isradipine; D008297:Male; D009599:Nitroprusside / Q000494:pharmacology*; D010069:Oxadiazoles / Q000494:pharmacology*; D011817:Rabbits; D012083:Renin / Q000097:blood*
D002121:Calcium Channel Blockers; D005292:Ferricyanides; D010069:Oxadiazoles; D009599:Nitroprusside; D006830:Hydralazine; D012083:Renin; D004078:Dihydralazine; D017275:Isradipine